4 Stories

CEO: Mylan Only Makes $50 Profit Per EpiPen

Heather Bresch testifies before Congress

(Newser) - Outraged Republican and Democratic lawmakers on Wednesday grilled the head of pharmaceutical company Mylan about the significant cost increase of its life-saving EpiPens and the profits for a company with sales in excess of $11 billion, the AP reports. Mylan CEO Heather Bresch held up an EpiPen as she told... More »

There's a Cheaper 'EpiPen,' but There's a Catch

Most people aren't trained on more-affordable Adrenaclick, which could lead to injuries

(Newser) - Not since Martin Shkreli has there been such outrage over the spiking costs of a life-saving device or drug. Mylan, the maker of the EpiPen, has bumped up costs by almost 500% over the past few years, and because the drugmaker enjoys a near-monopoly on the epinephrine-delivering device—the AP... More »

Rise in Food Allergies Means Big Business for EpiPen

Mylan lobbies to relax prescription rules for epinephrine injections

(Newser) - With severe food allergies on the rise in the United States, anaphylactic reactions are an increasing problem, especially at schools. But, in most states, school nurses risk losing their license if they give an epinephrine injection to a student who does not have a prescription—even though up to a... More »

As Kids' Allergies Soar, So Do Sales of EpiPens

Doctors prescribed nearly 2 million EpiPens in the US last year

(Newser) - Foods once thought of as wholesome—eggs, milk, wheat, peanut butter—now threaten the lives of some 3 million children with food allergies every year, MSNBC reports. As a result, US sales of EpiPens and their accessories are skyrocketing. These single-use shots of epinephrine can be self-administered and stop severe... More »

4 Stories